Ackermans & van Haaren: Nextensa might aim for ‘Proximus Towers' landmark project. D'Ieteren: Auto CEO sees Belgian new car market at 420k in 2025, down 6% YoY. Fastned: Preview of 4Q24 trading update. Proximus: HQ sale likely at price materially lower than expected. Randstad: 4Q24F results due 12 Feb, consensus released, negative earnings momentum. WDP: Sizeable acquisition in Belgium
Hyloris announced an exclusive license and supply agreement with Avenacy for tranexamic acid RTU in the US. The deal is set up as a profit sharing agreement with commercialisation expected to start in 2025. We reiterate our € 5 TP and Hold rating.
A director at Floridienne S.A. sold 2,000 shares at 510.000EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
AEGON: US WFG model in the spotlight again. BAM: Sells 50% of Invesis and tax fraud investigation finalised. Belgian Telecoms: Mobile Vikings targeting heavy data users with upgraded mobile-only offers. Universal Music Group: Acquires music services group Downtown Music for c.€737m. Events Calendar
Yesterday, Digi officially launched its commercial offering in Belgium, including Mobile, Broadband, TV and convergent offerings. At a mobile price of € 5/month for 15GB and broadband price of € 10/month for unlimited fiber with speeds of 500Mbps, pricing of its offering is highly competitive. Note however that the broadband offering is only available in a very small part of Brussels, meaning that competition in the short term will mainly come from Mobile, where Digi has a wholesale agreement wi...
Hyloris announced an exclusive license and supply agreement with Rosemont Pharmaceuticals for its Valacyclovir oral suspension in the US. In addition, the company appointed a new CFO, Christophe Maréchal, who previously served as CFO and co-CEO of Mithra. We reiterate our € 5 TP and HOLD rating.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.